Literature DB >> 30603597

Combined Treatment with Low-Level Laser and rhBMP-2 Promotes Differentiation and Mineralization of Osteoblastic Cells under Hypoxic Stress.

Jin-Ho Heo1, Jeong-Hun Choi1, In-Ryoung Kim2, Bong-Soo Park2, Yong-Deok Kim1,3.   

Abstract

BACKGROUND: The aim of this study was to evaluate the combined effect of low-level laser treatment (LLLT) and recombinant human bone morphological protein-2 (rhBMP-2) applied to hypoxic-cultured MC3T3-E1 osteoblastic cells and to determine possible signaling pathways underlying differentiation and mineralization of osteoblasts under hypoxia.
METHODS: MC3T3-E1 cells were cultured under 1% oxygen tension for 72 h. Cell cultures were divided into four groups: normoxia control, low-level laser (LLL) alone, rhBMP-2 combined with LLLT, and rhBMP-2 under hypoxia. Laser irradiation was applied at 0, 24, and 48 h. Cells were treated with rhBMP-2 at 50 ng/mL. Alkaline phosphatase activity was measured at 3, 7, and 14 days to evaluate osteoblastic differentiation. Cell mineralization was determined with Alizarin red S staining at 7 and 14 days. Western blot assays were performed to evaluate whether p38/protein kinase D (PKD) signaling was involved.
RESULTS: The results indicate that LLLT and rhBMP-2 synergistically increased alkaline phosphatase (ALP) activity and mineralization. Western blot analyses showed that expression of type I collagen, runt-related transcription factor 2 (RUNX2), and Osterix (Osx), increased and expression of hypoxia-inducible factor 1-alpha (HIF-1α), decreased more in the LLLT and rhBMP-2 combined group than in the rhBMP-2 or LLL alone groups. Moreover, LLLT and rhBMP-2 stimulated p38 phosphorylation and rhBMP-2 and LLLT increased Prkd1 phosphorylation.
CONCLUSION: Combined treatment with rhBMP-2 and LLL induced differentiation and mineralization of hypoxic-cultured MC3T3-E1 osteoblasts by activating p38/PKD signaling in vitro.

Entities:  

Keywords:  Hypoxia; Laser; Osteoblast; PKD; p38

Year:  2018        PMID: 30603597      PMCID: PMC6250649          DOI: 10.1007/s13770-018-0167-1

Source DB:  PubMed          Journal:  Tissue Eng Regen Med        ISSN: 1738-2696            Impact factor:   4.169


  38 in total

Review 1.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 2.  Macrophage responses to hypoxia: relevance to disease mechanisms.

Authors:  J S Lewis; J A Lee; J C Underwood; A L Harris; C E Lewis
Journal:  J Leukoc Biol       Date:  1999-12       Impact factor: 4.962

3.  Oxygen saturation in the bone marrow of healthy volunteers.

Authors:  Jonathan S Harrison; Pranela Rameshwar; Vicotr Chang; Persis Bandari
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 4.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

5.  Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro.

Authors:  D S Steinbrech; B J Mehrara; P B Saadeh; G Chin; M E Dudziak; R P Gerrets; G K Gittes; M T Longaker
Journal:  Plast Reconstr Surg       Date:  1999-09       Impact factor: 4.730

6.  Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation.

Authors:  A Suzuki; J Guicheux; G Palmer; Y Miura; Y Oiso; J P Bonjour; J Caverzasio
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

7.  Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells.

Authors:  S Gallea; F Lallemand; A Atfi; G Rawadi; V Ramez; S Spinella-Jaegle; S Kawai; C Faucheu; L Huet; R Baron; S Roman-Roman
Journal:  Bone       Date:  2001-05       Impact factor: 4.398

8.  Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation.

Authors:  Jérome Lemonnier; Chafik Ghayor; Jérome Guicheux; Joseph Caverzasio
Journal:  J Biol Chem       Date:  2003-10-22       Impact factor: 5.157

9.  Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.

Authors:  J Guicheux; J Lemonnier; C Ghayor; A Suzuki; G Palmer; J Caverzasio
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

10.  Hypoxia decreases Runx2/Cbfa1 expression in human osteoblast-like cells.

Authors:  J H Park; B H Park; H K Kim; T S Park; H S Baek
Journal:  Mol Cell Endocrinol       Date:  2002-06-28       Impact factor: 4.102

View more
  3 in total

Review 1.  Effect of low power lasers on prokaryotic and eukaryotic cells under different stress condition: a review of the literature.

Authors:  Adenilson de Souza da Fonseca; Larissa Alexsandra da Silva Neto Trajano; Eduardo Tavares Lima Trajano; Flavia de Paoli; Andre Luiz Mencalha
Journal:  Lasers Med Sci       Date:  2021-01-02       Impact factor: 3.161

2.  Laser and LED photobiomodulation effects in osteogenic or regular medium on rat calvaria osteoblasts obtained by newly forming bone technique.

Authors:  Matheus Völz Cardoso; Rebeca do Vale Placa; Adriana Campos Passanezi Sant'Ana; Sebastião Luiz Aguiar Greghi; Mariana Schutzer Ragghianti Zangrando; Maria Lucia Rubo de Rezende; Rodrigo Cardoso Oliveira; Carla Andreotti Damante
Journal:  Lasers Med Sci       Date:  2020-06-08       Impact factor: 3.161

3.  The Neuropeptide Spexin Promotes the Osteoblast Differentiation of MC3T3-E1 Cells via the MEK/ERK Pathway and Bone Regeneration in a Mouse Calvarial Defect Model.

Authors:  Freshet Assefa; Ju Ang Kim; Jiwon Lim; Sang-Hyeon Nam; Hong-In Shin; Eui Kyun Park
Journal:  Tissue Eng Regen Med       Date:  2021-12-24       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.